Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Forma Raises $100m In Quest To Become A Sickle Cell Leader

Dec 20 2019

• By Mandy Jackson

Finance Watch

Related Content

£88m Series B For Syncona-backed Freeline To Advance Liver Gene Therapy Focus

Jun 19 2018

Ultragenyx Gets Second Drug Approval; Crysvita With Kyowa Hakko Kirin

Apr 18 2018

Paratek's Antibiotic Nuzyra Survived 20 Years – Now For The US Launch

Oct 03 2018

Finance Watch: Investment In Novel Antibacterials Gets A New Boost With Qpex Launch

Oct 23 2018

Forma and Celgene form a protein homeostasis deal

Apr 30 2013

New EU Approvals

Dec 04 2019

New US venture aiming for novel oncology targets

Jan 09 2009

Finance Watch: Relay Raises $400m – And It's Only The Third-Largest Biopharma VC Round Of 2018

Dec 21 2018

Global Blood Therapeutics' Oxbryta Approved Broadly For Sickle Cell Disease

Nov 26 2019

4-in-1 deal: Forma grabs $225m from Celgene

Apr 02 2014

Forma raises $25.5 million

Dec 02 2009

Surprise As FDA Approves Sarepta’s Duchenne Drug Vyondys 53

Dec 13 2019

Finance Watch: Omega, Perceptive/Xontogeny Raise $648m For Life Science Investments

Dec 12 2019

Pipeline Watch: The ASH Bumper Edition

Dec 17 2019

Axsome Soars After Depression Trial Success

Dec 17 2019

Forma nets $65M upfront from Boehringer to drug "undruggable" cancer targets

Jan 06 2012

Related Companies

Forma Therapeutics Inc.

Bristol Myers Squibb Company

Novartis AG

Johnson & Johnson

Genentech, Inc.

Boehringer Ingelheim GmbH

Bristol Myers Squibb Company

Spur Therapeutics Limited

Qpex Biopharma, Inc.

Immuneering Corporation

Ultragenyx Pharmaceutical Inc.

Kyowa Kirin Co., Ltd.

Bausch Health Companies Inc.

Paratek Pharmaceuticals, Inc.

Sarepta Therapeutics, Inc.

Axsome Therapeutics, Inc.

Global Blood Therapeutics, Inc.

Abeona Therapeutics Inc.

Additional Topics

Financing Business Strategies Rare Diseases StartUps and SMEs Deals Commercial BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window